The U.S. awards Raytheon a $22.9 billion (about $23 billion) contract to accelerate production of Tomahawk cruise missiles. Multiple outlets describe the deal as a seven-year effort aimed at rebuilding depleted stocks of high-tech munitions.
Several reports link the contract to post-Iran-war replenishment needs and a broader munitions shortage, saying the U.S. is working to restore inventories used by Washington and supplied to allies. Breaking Defense adds that multiyear contracts are being used to encourage major defense firms to invest more in production facilities and supply chains.
While coverage is broadly consistent on the contract value and purpose, Fox News characterizes the context as tied to President Donald Trump dismissing concerns about weapon stockpiles. Other outlets focus less on political debate and more on the operational and industrial base rationale. The Jerusalem Post and The Independent also highlight that the deal supports resupply to allies and cite large projected increases in annual output.
